Research graph
References from Latest updates in quality of life and psychological impact of sarcoidosis. Local targets link to admitted publications; unresolved targets remain external evidence.
Quality of life of couples living with sarcoidosis
2019 · External reference
Breaking barriers: holistic assessment of ability to work in patients with sarcoidosis
10.1016/s2213-2600(24)00297-2 · 2024 · External reference
Health-related quality of life assessment in sarcoidosis
10.1016/j.ccm.2023.08.009 · 2024 · External reference
Health-related quality of life (HRQoL) in sarcoidosis: diagnosis, management, and health outcomes
10.3390/diagnostics11061089 · 2021 · External reference
Quality of life in sarcoidosis
10.1016/j.jaut.2023.103123 · 2024 · External reference
A snapshot of united states sarcoidosis patients and their perceived disease impact: results of the Sarcoidosis Research Institute Survey
10.1007/s00408-024-00761-8 · 2025 · External reference
Use of fatigue assessment scale and small fiber neuropathy screening list in Japanese patients with sarcoidosis
2025 · External reference
Peripheral neuropathy in sarcoidosis
10.1016/j.jneuroim.2022.577864 · 2022 · External reference
Infliximab decreases inflammatory activity but has no effect on small fiber neuropathy related symptoms in Dutch patients with sarcoidosis
2022 · External reference
Severe fatigue is highly prevalent in patients with IPF or sarcoidosis
10.3390/jcm9041178 · 2020 · External reference
Respiratory and nonrespiratory symptoms in patients with IPF or sarcoidosis and controls
10.1016/j.hrtlng.2023.05.013 · 2023 · External reference
Peripheral levels of selected biomarkers in patients with post-sarcoidosis chronic fatigue syndrome
10.2147/jir.s549445 · 2025 · External reference
Chronotype and the Big-Five personality traits as predictors of chronic fatigue among patients with sarcoidosis. A cross-sectional study
2023 · External reference
Prevalence and characteristics of self-reported hypothyroidism and its association with nonorgan-specific manifestations in US sarcoidosis patients: a nationwide registry study
10.1183/23120541.00754-2020 · 2021 · External reference
Comorbidities of sarcoidosis
10.1080/07853890.2022.2063375 · 2022 · External reference
Assessment of disease burden among Japanese patients with pulmonary sarcoidosis: a questionnaire-based study
2025 · External reference
Economic burden of sarcoidosis in a commercially-insured population in the United States
10.1080/13696998.2017.1351371 · 2017 · External reference
Sarcoidosis and work participation: the need to develop a disease-specific core set for assessment of work ability
10.1007/s00408-019-00234-3 · 2019 · External reference
Cognitive difficulties and health-related quality of life in sarcoidosis: an analysis of the GRADS Cohort
10.3390/jcm11133594 · 2022 · External reference
Neuropsychiatric manifestations of sarcoidosis
10.1080/07853890.2024.2445191 · 2025 · External reference
Psychiatric symptoms and syndromes in sarcoidosis: a systematic review and meta-analysis
10.3389/fmed.2025.1634175 · 2025 · External reference
Risk of depression and anxiety in 7.302 patients with sarcoidosis: a nationwide cohort study
2024 · External reference
Anxiety and depression in sarcoidosis: the influence of age, gender, affected organs, concomitant diseases and dyspnea
2012 · External reference
The impact of the unknown: patient experiences with uncertainty in sarcoidosis
10.1016/j.chest.2025.06.025 · 2025 · External reference
Income and other contributors to poor outcomes in U.S. patients with sarcoidosis
10.1164/rccm.201906-1250oc · 2020 · External reference
Psychological burden associated with worse clinical outcomes in sarcoidosis
10.1136/bmjresp-2019-000467 · 2019 · External reference
Assessment of dyspnea in sarcoidosis using the Baseline Dyspnea Index (BDI) and the Transition Dyspnea Index (TDI)
10.1016/j.rmed.2021.106436 · 2022 · External reference
Predictors of objective cough frequency in pulmonary sarcoidosis
10.1183/13993003.01369-2015 · 2016 · External reference
Predictors of cough-specific and generic quality of life in sarcoidosis patients
2020 · External reference
Updates on the prevalence, quality of life, and management of chronic cough in interstitial lung diseases
10.3390/diagnostics15091139 · 2025 · External reference
The burden of cough in idiopathic pulmonary fibrosis and other interstitial lung diseases: a systematic evidence synthesis
10.1186/s12931-024-02897-w · 2024 · External reference
FeV1 and BMI influence King's Sarcoidosis Questionnaire score in sarcoidosis patients
10.1186/s12890-021-01761-7 · 2021 · External reference
Contribution of peripheral airways dysfunction to poor quality of life in sarcoidosis
10.1016/j.chest.2025.02.036 · 2025 · External reference
The association of baseline sarcoidosis measurements with 6-month outcomes that are of interest to patients: results from the On-line Sarcoidosis Assessment Platform Study (OSAP)
10.1016/j.rmed.2022.106819 · 2022 · External reference
Functional capacity, quality of life, and disability in fibrosing interstitial lung disease: Insights into pulmonary function and outcomes
2025 · External reference
Drug-induced comorbidities in patients with sarcoidosis
10.1097/mcp.0000000000000889 · 2022 · External reference
The effect of corticosteroids on quality of life in a sarcoidosis clinic: the results of a propensity analysis
10.1016/j.rmed.2015.01.019 · 2015 · External reference
Type 2 diabetes risk in sarcoidosis patients untreated and treated with corticosteroids
10.1183/23120541.00028-2021 · 2021 · External reference
Incidence of new comorbidities after steroid use in patients with sarcoidosis: an international cross-sectional survey
10.1016/j.chest.2025.11.048 · 2025 · External reference
Effectiveness and tolerability of methotrexate in pulmonary sarcoidosis: a single center real-world study
2019 · External reference
Obstructive sleep apnea in sarcoidosis and impact of CPAP treatment on fatigue
2020 · External reference
The prevalence of obstructive sleep apnea in sarcoidosis and its impact on sleepiness, fatigue, and sleep-associated quality of life: a cross-sectional study with matched controls (the OSASA study)
10.5664/jcsm.10140 · 2022 · External reference
Risk and predictors of heart failure in sarcoidosis in a population-based cohort study from Sweden
10.1136/heartjnl-2021-319129 · 2022 · External reference
Gender differences in health-related quality of life measured by the Sarcoidosis Health Questionnaire
10.1038/s41598-021-89383-1 · 2021 · External reference
Quality of life, fatigue and markers in sarcoidosis: a section from Turkey
2024 · External reference
Uncovering sex and gender differences in sarcoidosis: a systematic review of current evidence
10.3390/jpm16010024 · 2026 · External reference
Short-term particulate air pollution exposure is associated with increased severity of respiratory and quality of life symptoms in patients with fibrotic sarcoidosis
10.3390/ijerph15061077 · 2018 · External reference
Health-related quality of life in sarcoidosis patients and the effect of occupational exposures: a cross-sectional study
10.1186/s12890-025-03552-w · 2025 · External reference
PROMs in sarcoidosis - what to use for systemic disease and individual organs and why?
10.1097/mcp.0000000000001203 · 2025 · External reference
Evaluating the minimal clinically important difference of the King's Sarcoidosis Questionnaire in a multicenter prospective study
10.1513/annalsats.202006-607oc · 2021 · External reference
Optimizing patient-reported outcomes for sarcoidosis
10.1016/j.coi.2025.102720 · 2026 · External reference
First-line treatment of pulmonary sarcoidosis with prednisone or methotrexate
10.1056/nejmoa2501443 · 2025 · External reference
Quality of life and physical activity in 629 individuals with sarcoidosis: prospective, cross-sectional study using smartphones (Sarcoidosis App)
10.2196/38331 · 2022 · External reference
Innovating care for people with sarcoidosis using a machine learning-driven approach
10.1186/s12931-025-03282-x · 2025 · External reference
Multidisciplinary strategies and new technologies in the management of sarcoidosis
10.1016/j.ejim.2025.106576 · 2026 · External reference
The effects of pharmacological interventions on quality of life and fatigue in sarcoidosis: a systematic review
10.1183/16000617.0057-2019 · 2020 · External reference
ERS clinical practice guidelines on treatment of sarcoidosis
10.1183/13993003.04079-2020 · 2021 · External reference
A paradigm shift in corticosteroid therapy for sarcoidosis: a World Association of Sarcoidosis and Other Granulomatous Disorders Position Paper, endorsed by the Americas Association of Sarcoidosis and Other Granulomatous Disorders
10.1016/s2213-2600(25)00338-8 · 2025 · External reference
Sarcoidosis: a state-of-the-art review
10.1183/13993003.01324-2025 · 2026 · External reference
Feasibility of investigating methylphenidate for the treatment of sarcoidosis-associated fatigue (the FaST-MP study): a double-blind, parallel-arm randomised feasibility trial
10.1136/bmjresp-2020-000814 · 2021 · External reference
Azithromycin for sarcoidosis cough: an open-label exploratory clinical trial
10.1183/23120541.00534-2020 · 2020 · External reference
Nutrition and corticosteroids in the treatment of sarcoidosis
10.1097/mcp.0000000000000501 · 2018 · External reference
The short- and long-term impact of pulmonary rehabilitation in subjects with sarcoidosis: a prospective study and review of the literature
2021 · External reference
Does physical training reduce fatigue in sarcoidosis?
2015 · External reference
Pulmonary rehabilitation in sarcoidosis: a systematic review and meta-analysis
10.1016/j.rmed.2023.107432 · 2023 · External reference
High-intensity resistance training in newly diagnosed sarcoidosis- an exploratory study of effects on lung function, muscle strength, fatigue, dyspnea, health-related quality of life and lung immune cells
10.1080/20018525.2020.1730137 · 2020 · External reference
Comparison of the effects of one-legged and two-legged exercise training on exercise capacity and fatigue in patients with sarcoidosis
10.1016/j.rmed.2025.108380 · 2025 · External reference
Telerehabilitation for chronic respiratory disease: a randomised controlled equivalence trial
10.1136/thoraxjnl-2021-216934 · 2022 · External reference
Telehealth in sarcoidosis: a scoping review
10.1186/s12890-025-03528-w · 2025 · External reference
Online mindfulness-based cognitive therapy for fatigue in patients with sarcoidosis (TIRED): a randomised controlled trial
10.1016/s2213-2600(22)00387-3 · 2023 · External reference
Perceptions of the fatigue experience and a breathing awareness meditation-integrated mhelath app for fatigue and stress in patients with sarcoiidosis
10.1080/21641846.2022.2154499 · 2023 · External reference
Design and rationale of a pilot randomized clinical trial investigating the use of a mHealth app for sarcoidosis-associated fatigue
10.1016/j.conctc.2023.101062 · 2023 · External reference
A mHealth app for sarcoidosis-associated fatigue: a feasibility randomized control trial
10.1016/j.rmed.2025.108490 · 2025 · External reference
